New study shows Smith+Nephew foam dressing absorbs 93% of shear forces

LONDON - Smith+Nephew’s (NYSE:SNN; LSE:SN), a medical technology company with a market capitalization of $14.27 billion and trading near its InvestingPro Fair Value, announced its ALLEVYN COMPLETE CARE Foam Dressing absorbs 93% of mechanical energy that can cause pressure injuries, according to new research published in the International Wound Journal.

The study, conducted by Professor Amit Gefen’s research group at Tel Aviv University, demonstrated the dressing’s mechanism of action in preventing pressure injuries by absorbing and dissipating friction and shear forces through its internal layers.

Using Frictional Energy Absorber Effectiveness (FEAE) and Finite Element Modelling (FEM), researchers confirmed the dressing’s ability to mitigate mechanical loading and protect underlying soft tissue.

"ALLEVYN COMPLETE CARE Dressing’s advanced biomechanical performance dissipates potentially harmful shear forces, which can help protect patients from factors that contribute to pressure injuries," said Professor Gefen.

The new dressing shows significant improvement over previous technology, increasing frictional energy absorption from 30-45% to 93%, according to the press release.

Pressure injuries, which result from prolonged exposure to pressure combined with shear forces, cost the US healthcare system over $26.8 billion annually.

Smith+Nephew plans to launch ALLEVYN COMPLETE CARE Dressing in the US advanced wound care market later this year, with expansion to other markets throughout 2026. The product is indicated for wound management and pressure injury prevention.

The medical technology company reported annual sales of $5.8 billion in 2024 and operates in approximately 100 countries. With impressive revenue growth of 23.48% and an overall GREAT financial health rating according to InvestingPro, which offers 12 additional valuable insights about the company’s performance and prospects in its comprehensive Pro Research Report. The company maintains strong profitability with a gross margin of 48.39%.

In other recent news, SharkNinja Inc. reported impressive second-quarter earnings for 2025, significantly surpassing Wall Street expectations. The company achieved an earnings per share of $0.97, well above the forecasted $0.57, and reported revenues of $1.44 billion, exceeding the anticipated $1.07 billion. Guggenheim responded to these results by raising SharkNinja’s stock price target from $120 to $140, maintaining a Buy rating due to the company’s notable 15.7% net sales growth amidst industry declines. Additionally, SharkNinja announced a secondary offering of 5 million ordinary shares by certain selling shareholders affiliated with CJ Xuning Wang, the Chairperson of the board. This offering includes a 30-day option for underwriters to purchase up to an additional 750,000 shares. In a separate development, SharkNinja disclosed that Chief Financial Officer Patraic Reagan will resign effective September 5, 2025, clarifying that his departure is not due to any disputes with the company. These events reflect ongoing changes and strategic moves within SharkNinja.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.